Lantheus Holdings (LNTH) Goodwill & Intangibles (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Goodwill & Intangibles came in at $1.2 billion in Q1 2026, up 447.08% year-on-year from $214.9 million in Q1 2025, and up 22.19% on a QoQ basis from $962.3 million in Q4 2025.
Lantheus Holdings (LNTH) Goodwill & Intangibles (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Goodwill & Intangibles data on file, last reported at $1.2 billion in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles rose 447.08% year-over-year to $1.2 billion in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 447.08% increase from a year earlier, with the FY2025 full-year figure at $962.3 million, up 331.62% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $1.2 billion, up from $962.3 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for LNTH reached as high as $1.2 billion in Q3 2025 and fell as low as $101.5 million in Q2 2024.
- Historically, Goodwill & Intangibles has averaged $434.5 million across 5 years, with a median of $282.2 million in 2023.
- Across the five-year window, Goodwill & Intangibles sank 64.04% in 2024 and soared 447.08% in 2026, its largest moves.
- Year by year, Goodwill & Intangibles stood at $376.5 million in 2022, then tumbled by 43.38% to $213.2 million in 2023, then rose by 4.59% to $223.0 million in 2024, then soared by 331.62% to $962.3 million in 2025, then rose by 22.19% to $1.2 billion in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $1.2 billion in Q1 2026, $962.3 million in Q4 2025, and $1.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.18 Bn |
| Dec 31, 2025 | 962.30 Mn |
| Sep 30, 2025 | 1.18 Bn |
| Jun 30, 2025 | 536.82 Mn |
| Mar 31, 2025 | 214.93 Mn |
| Dec 31, 2024 | 222.95 Mn |
| Sep 30, 2024 | 234.80 Mn |
| Jun 30, 2024 | 101.49 Mn |
| Mar 31, 2024 | 203.24 Mn |
| Dec 31, 2023 | 213.17 Mn |
| Sep 30, 2023 | 224.48 Mn |
| Jun 30, 2023 | 282.19 Mn |
| Mar 31, 2023 | 281.05 Mn |
| Dec 31, 2022 | 376.47 Mn |
| Sep 30, 2022 | 384.78 Mn |
| Jun 30, 2022 | 393.09 Mn |
| Mar 31, 2022 | 401.39 Mn |
| Dec 31, 2021 | 409.70 Mn |
| Sep 30, 2021 | 418.07 Mn |
| Jun 30, 2021 | 426.45 Mn |